Physician profile
Mohammed Osman
NPI 1326455213
$2,161.45
in general payments reported to CMS, 2019-2025
16 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $175 · 2022: $473 · 2023: $543 · 2024: $376 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $508.61 | 2021-2024 | Endurant Iis, Onyx Frontier |
| Endologix LLC | $379.29 | 2022 | |
| Abbott Laboratories | $273.02 | 2025 | Mitraclip, Triclip, Aveir |
| Cook Medical LLC | $268.52 | 2019-2025 | Lunderquist, Zenith Alpha |
| Penumbra, INC. | $156.18 | 2023 | Indigo System |
| Bolton Medical INC | $113.65 | 2024-2025 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $108.00 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Takeda Pharmaceuticals U.S.A., INC. | $93.41 | 2022 | |
| Amneal Pharmaceuticals LLC | $80.91 | 2019 | |
| Bard Peripheral Vascular, INC. | $49.97 | 2023 | Venovo |
| Astrazeneca Pharmaceuticals LP | $34.99 | 2024 | Enhertu |
| Solventum Corporation | $28.66 | 2025 | Prevena, Abthera Advance |
| Shockwave Medical, INC | $22.65 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $16.33 | 2021 | |
| Boston Scientific Corporation | $14.36 | 2023 | Watchman Access System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.90 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Osman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.